(169 days)
Not Found
No
The summary describes a mechanical device (balloon catheter and syringes) and its performance testing, with no mention of software, algorithms, or data processing that would indicate AI/ML.
Yes.
The device is indicated for "balloon dilatation of the stenotic portion of a coronary artery or bypass graft for the purpose of improving myocardial perfusion" and "post delivery expansion of balloon expandable stents within the coronary vasculature," which are therapeutic interventions.
No
Explanation: The device is a balloon catheter primarily used for therapeutic purposes like dilating stenotic coronary arteries or bypass grafts and post-delivery expansion of stents. It is not designed to diagnose a condition.
No
The device description clearly outlines a physical medical device (balloon catheter, syringes) and the performance studies focus on bench testing of hardware components. There is no mention of software as a component or function of the device.
Based on the provided information, the FLASH Mini Ostial System is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use is for balloon dilatation of coronary arteries and bypass grafts to improve blood flow and for post-delivery expansion of coronary stents. This is a therapeutic procedure performed directly on the patient's body.
- Device Description: The device is a catheter with balloons designed for mechanical intervention within the coronary vasculature.
- Lack of In Vitro Testing: The performance studies described are primarily in-vitro bench testing of the device's physical characteristics and performance, not testing of biological samples (like blood, tissue, etc.) to diagnose or monitor a condition.
- Anatomical Site: The device is used within the coronary artery and bypass graft, which are internal anatomical sites. IVDs typically analyze samples taken from the body.
In Vitro Diagnostic devices are used to examine specimens derived from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, prevention, or treatment of a disease or condition. The FLASH Mini Ostial System is a medical device used for a therapeutic intervention within the body.
N/A
Intended Use / Indications for Use
The FLASH Mini Ostial System is indicated for balloon dilatation of the stenotic portion of a coronary artery or bypass graft for the purpose of improving myocardial perfusion. The FLASH Mini Ostial System is also indicated for the post delivery expansion of balloon expandable stents within the coronary vasculature.
Product codes
LOX
Device Description
The FLASH Mini Ostial System is a 0.014" guidewire-compatible, rapid exchange (RX) coronary angioplasty balloon catheter with a working length of 135cm. The FLASH Mini Ostial System uses a dual balloon design that features a complaint Proximal Balloon which prevents distal migration of the balloon during angioplasty. The second semi-compliant higher-pressure balloon allows for luminal dilatation of de novo lesions and post deployment stent expansion.
The FLASH Mini Ostial System is packaged with two accessory syringes. A standard 10cc syringe intended for use in deflation of the Proximal Balloon and a 1.0cc syringe with a pressure relief feature intended for use in inflation of the Proximal Balloon. The pressure relief feature is intended to improve patient safety by limiting the maximum achievable pressure in the Proximal Balloon if the user attempts to inflate the Proximal Balloon when incorrectly positioned.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
coronary artery or bypass graft
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The 1.0cc accessory syringe components with the pressure relief feature, herein referred to as the Pressure Relief Syringe, were evaluated for the following in-vitro and performance bench testing to confirm the performance characteristics as compared to the product performance requirements:
Pressure Relief Syringe Performance Requirements
- Minimum Expansion Pressure
- Maximum Expansion Pressure
- Freedom from Leakage
Balloon Catheter Compatibility Requirements
- Proximal Balloon Inflation Time
- Simulated Use and Proximal Balloon Inflation Port Compatibility
All test results demonstrate that the pressure relief feature does not impact the use of the device under normal operating conditions. Additionally, the test result demonstrates that the Pressure Relief Syringe consistently limits the maximum pressure that can be achieved in the Proximal Balloon.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.5100 Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter.
(a)
Standard PTCA Catheter —(1)Identification. A PTCA catheter is a device that operates on the principle of hydraulic pressurization applied through an inflatable balloon attached to the distal end. A PTCA balloon catheter has a single or double lumen shaft. The catheter features a balloon of appropriate compliance for the clinical application, constructed from a polymer. The balloon is designed to uniformly expand to a specified diameter and length at a specific pressure as labeled, with well characterized rates of inflation and deflation and a defined burst pressure. The device generally features a type of radiographic marker to facilitate fluoroscopic visualization of the balloon during use. A PTCA catheter is intended for balloon dilatation of a hemodynamically significant coronary artery or bypass graft stenosis in patients evidencing coronary ischemia for the purpose of improving myocardial perfusion. A PTCA catheter may also be intended for the treatment of acute myocardial infarction; treatment of in-stent restenosis (ISR) and/or post-deployment stent expansion.(2)
Classification. Class II (special controls). The special control for this device is “Class II Special Controls Guidance Document for Certain Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters.” See § 870.1(e) for the availability of this guidance document.(b)
Cutting/scoring PTCA Catheter —(1)Identification. A cutting/scoring PTCA catheter is a balloon-tipped catheter with cutting/scoring elements attached, which is used in those circumstances where a high pressure balloon resistant lesion is encountered. A cutting/scoring PTCA catheter is intended for the treatment of hemodynamically significant coronary artery stenosis for the purpose of improving myocardial perfusion. A cutting/scoring PTCA catheter may also be indicated for use in complex type C lesions or for the treatment of in-stent restenosis.(2)
Classification. Class III (premarket approval). As of May 28, 1976, an approval under section 515 of the act is required before this device may be commercially distributed. See § 870.3.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, stacked on top of each other.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
February 16, 2016
Ostial Corporation Jake Wolenberg Quality Assurance and Regulatory Affairs Manager 1221 Innsbruck Drive Sunnyvale, CA 94089
Re: K152485
Trade/Device Name: FLASH Mini Ostial System (3.0mm x 8mm x 135cm, 3.5mm x 8mm x 135cm, 4.0mm x 8mm x 135cm, and 4.5mm x 8mm x 135cm) Regulation Number: 21 CFR 870.5100 Regulation Name: Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter Regulatory Class: Class II Product Code: LOX Dated: January 25, 2016 Received: January 27, 2016
Dear Mr. Wolenberg:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in
1
Page 2 - Jake Wolenberg
the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Kenneth J. Cavanaugh -S
for
for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K152485
Device Name FLASH Mini Ostial System
Indications for Use (Describe)
The FLASH Mini Ostial System is indicated for balloon dilatation of the stenotic portion of a coronary artery or bypass graft for the purpose of improving myocardial perfusion. The FLASH Mini Ostial System is also indicated for the post delivery expansion of balloon expandable stents within the coronary vasculature.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for Ostial Corporation. The logo consists of a geometric shape on the left and the company name on the right. The geometric shape is a stylized flower or star-like design with alternating blue and gray segments. The word "Ostial" is in gray, and the word "corporation" is in blue, with a blue line separating the two words.
Ostial Corporation 510(k) Notification: FLASH Mini Ostial System Pressure Relief Syringe
Ostial Corporation 1221 Innsbruck Drive Sunnyvale, CA 94089 t. (408) 541-1006 f. (408) 541-1007
510(k) Summary FLASH Mini Ostial System 1.0cc Accessory Syringe Component Modification to Include a Pressure Relief Feature
A. Submitter Information
Submitter's Name: Address:
Telephone: Fax: Email: Contact Person: Date of Preparation:
B. Subject Device
Proprietary Name: Common/Usual Name: Classification Name:
Product Code:
C. Predicate Device Name
Proprietarv Name: 510(k) #'s: Common/Usual Name: Classification Name:
Product Code:
Ostial Corporation 1221 Innsbruck Drive Sunnyvale, CA 94089 408-541-1006 408-541-1007 jwolenberg@ostialcorp.com Jake Wolenberg August 20, 2015
FLASH Mini Ostial System PTCA Catheter Catheters, Transluminal Coronary Angioplasty, Percutaneous LOX per 21 C.F.R. 870.5100
FLASH Mini Ostial System K131450 PTCA Catheter Catheters, Transluminal Coronary Angioplasty, Percutaneous LOX per 21 C.F.R. 870.5100
D. Device Description:
The FLASH Mini Ostial System is a 0.014" guidewire-compatible, rapid exchange (RX) coronary angioplasty balloon catheter with a working length of 135cm. The FLASH Mini Ostial System uses a dual balloon design that features a complaint Proximal Balloon which prevents distal migration of the balloon during angioplasty. The second semi-compliant higher-pressure balloon allows for luminal dilatation of de novo lesions and post deployment stent expansion.
The FLASH Mini Ostial System is packaged with two accessory syringes. A standard 10cc syringe intended for use in deflation of the Proximal Balloon and a 1.0cc syringe with a pressure relief feature intended for use in inflation of the Proximal Balloon. The pressure relief feature is intended to improve patient safety by limiting the maximum achievable pressure in the Proximal Balloon if the user attempts to inflate the Proximal Balloon when incorrectly positioned.
4
Image /page/4/Picture/0 description: The image contains the logo for Ostial Corporation. The logo consists of a circular design on the left, resembling a stylized flower or gear, with alternating light blue and gray elements. To the right of the circular design is the word "Ostial" in a dark gray sans-serif font, with the word "corporation" in a light blue sans-serif font underneath, separated by a horizontal line.
Ostial Corporation 510(k) Notification: FLASH Mini Ostial System Pressure Relief Svringe
Ostial Corporation 1221 Innsbruck Drive Sunnyvale, CA 94089 t. (408) 541-1006 f. (408) 541-1007
E. Intended Use:
The FLASH Mini Ostial System is indicated for balloon dilatation of the stenotic portion of a coronary artery or bypass graft for the purpose of improving myocardial perfusion. The FLASH Mini Ostial System is also indicated for the post delivery expansion of balloon expandable stents within the coronary vasculature.
F. Summary of Similarities and Differences in Technological Characteristics, Performance and Intended Use:
There are no changes being made to the balloon catheters or the 10cc accessory portions of the FLASH Mini Ostial System. The only change being proposed in this traditional 510(k) is the incorporation of a pressure relief feature for the 1.0cc accessory syringe component intended to be used to inflate the Proximal Balloon.
The pressure relief feature is achieved by creating a small hole in barrel of the 1.0cc syringe. A piece of complaint silicone tubing is secured over the hole. When the pressure in the syringe exceeds a certain level, fluid leaves through the hole and starts to fill the silicone tubing instead of the Proximal Balloon. This limits the maximum pressure achievable in the Proximal Balloon to a level that will not result in significant expansion, even if the user inflates the balloons while the device is incorrectly positioned.
The incorporation of the pressure relief feature to the 1.0cc accessory syringe component does not affect the device's operating principles or mechanism of action (the balloon catheters remain exactly the same and 1.0cc syringe still functions via manual depression of a plunger). In addition, the same materials and processes used to make the currently cleared FLASH Mini Ostial System are used for the 1.0cc accessory syringe component with the pressure relief feature.
The addition of the pressure relief feature does not affect the intended use of the FLASH Mini Ostial System. The Indications for Use remain exactly the same.
The Pressure Relief Svringe is intended to be packaged with all of the device sizes in the FLASH Mini Ostial System product family currently cleared under 510(k) # K131450. A summary of the currently cleared device sizes can be found in the table below.
| 510(k)
Number | Clearance
Date | Device Sizes1 |
|------------------|-------------------|------------------------------------------------------------------------------------------|
| K131450 | August 6, 2013 | 3.0mm x 8mm x 135cm
3.5mm x 8mm x 135cm
4.0mm x 8mm x 135cm
4.5mm x 8mm x 135cm |
|--|
Note 1 - Balloon Diameter x Balloon Length x Catheter Length
5
Image /page/5/Picture/0 description: The image contains the logo for Ostial Corporation. The logo consists of a circular design on the left, resembling a stylized flower or gear, with alternating light blue and gray segments. To the right of the circular design is the word "Ostial" in a gray, sans-serif font. Below "Ostial" is the word "corporation" in a smaller, light blue font, underlined with a light blue line.
Ostial Corporation 510(k) Notification: FLASH Mini Ostial System Pressure Relief Syringe
Ostial Corporation 1221 Innsbruck Drive Sunnyvale, CA 94089 t. (408) 541-1006 f. (408) 541-1007
G. Previously Presented Performance Data:
As there are no changes being made to the FLASH Mini Ostial System balloon catheters, the previously collected performance data presented in special 510(k) K131450 remains valid. The previously presented data has been summarized for reference below. Note that as the data remains unchanged, it is not presented in the main body of this traditional 510(k). Please refer to Special 510(k) K131450 for this data.
Balloon Catheter Performances Data Previously Presented in 510(k) K131450
Biocompatibility testing has previously been completed on product equivalent to the FLASH Mini Ostial System. Requirements for biological evaluation of the proposed device were based on the Blue Book Memorandum issued on May 1, 1995, Use of International Standard ISO-10993, "Biological Evaluation of Medical Devices, Part 1: Evaluation and Testing." The biocompatibility test results show that the materials used in the design and manufacture of the components of the proposed device are non-toxic and non-sensitizing to biological tissues consistent with its intended use. The following biocompatibility tests were completed:
- ISO MEM Elution Assay
- ASTM Hemolysis Assay
- Complement Activation C3a and SC5b-9 Assay ●
- . Thromboresistance Evaluation
- Materials Mediated Rabbit Pyrogen
- ISO Guinea Pig Maximization Sensitization
- ISO Acute Systemic Injection Test ●
- . ISO Intracutaneous Reactivity Test
- Pyrogen (LAL) Chromogenic ●
The FLASH Mini Ostial System or product equivalent was evaluated using the following in-vitro performance bench testing to confirm the performance characteristics as compared to the product performance requirements:
- . Balloon Crossing Profile
- Catheter Shaft Diameter
- Catheter Working Length
- Catheter Inner Diameter ●
- Angioplasty Balloon Rated Burst Pressure ●
- . Proximal Balloon Burst Volume
- Angioplasty Balloon Compliance
- . Balloon Inflation Time
- Balloon Deflation Time
- Angioplasty Balloon Rated Burst Pressure (in 0 Stent)
- Proximal Balloon Burst Volume (in Stent)
- Angioplasty Balloon Fatigue
- Proximal Balloon Fatigue ●
- Catheter Bond Strength
- Catheter Tip Pull Strength
- Catheter Torque Strength ●
- Simulated Use
- Flexibility and Kink Resistance o
- Radiopacity ●
- Angioplasty Balloon Fatigue (in Stent) ●
- Proximal Balloon Fatigue (in Stent) ●
6
Image /page/6/Picture/0 description: The image shows the logo for Ostial Corporation. The logo consists of a stylized, interconnected ring on the left, with the word "Ostial" in gray to the right of the ring. Below "Ostial" is a blue line, and below that is the word "corporation" in blue. The ring is made up of alternating blue and gray segments.
Ostial Corporation 510(k) Notification: FLASH Mini Ostial System Pressure Relief Syringe
H. New Performance Data:
As the purpose of this Traditional 510(k) is to request clearance for the incorporation of a pressure relief feature for the 1.0cc accessory syringe component included with the FLASH Mini Ostial System product line, the performance data presented herein focuses on the functionality of the pressure relief feature and ensuring that the syringe remains compatible with the balloon catheter.
The 1.0cc accessory syringe components with the pressure relief feature, herein referred to as the Pressure Relief Syringe, were evaluated for the following in-vitro and performance bench testing to confirm the performance characteristics as compared to the product performance requirements:
Pressure Relief Syringe Performance Requirements
- Minimum Expansion Pressure ●
- Maximum Expansion Pressure .
- Freedom from Leakage o
Balloon Catheter Compatibility Requirements
- Proximal Balloon Inflation Time ●
- Simulated Use and Proximal Balloon Inflation Port Compatibility .
All test results demonstrate that the pressure relief feature does not impact the use of the device under normal operating conditions. Additionally, the test result demonstrates that the Pressure Relief Syringe consistently limits the maximum pressure that can be achieved in the Proximal Balloon.
I. Conclusions:
All test results demonstrated that the accessory Pressure Relief Syringe component of the FLASH Mini Ostial System meets all predetermined design verification and validation acceptance criteria necessary to verify safe and consistent performance of the Pressure Relief Syringe. As such, Ostial Corporation is requesting clearance for the addition of the pressure relief feature to the 1.0cc inflation syringe included with all FLASH Mini Ostial System device sizes, which were most recently cleared via Premarket Notification 510(k) #K131450 on August 6, 2013.